Published in Neuropsychopharmacology on March 03, 2010
Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry (2013) 1.69
Current status of the polyamine research field. Methods Mol Biol (2011) 1.33
The molecular bases of the suicidal brain. Nat Rev Neurosci (2014) 1.02
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. Gut Pathog (2013) 0.88
Sensitive periods in epigenetics: bringing us closer to complex behavioral phenotypes. Epigenomics (2012) 0.87
Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One (2010) 0.84
Suicide and the polyamine system. CNS Neurol Disord Drug Targets (2013) 0.82
Rapid assembly and collective behavior of microtubule bundles in the presence of polyamines. Biophys J (2011) 0.81
The neurobiology of suicide - A Review of post-mortem studies. J Mol Psychiatry (2013) 0.79
Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission. Neurosci Biobehav Rev (2016) 0.78
An overview of the neurobiology of suicidal behaviors as one meta-system. Mol Psychiatry (2014) 0.77
Epigenetics and suicidal behavior research pathways. Am J Prev Med (2014) 0.77
Arginase and Arginine Decarboxylase - Where Do the Putative Gate Keepers of Polyamine Synthesis Reside in Rat Brain? PLoS One (2013) 0.75
Neuropathology of suicide: recent findings and future directions. Mol Psychiatry (2017) 0.75
Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol (1995) 3.26
A perspective of polyamine metabolism. Biochem J (2003) 3.24
Modulation of cellular function by polyamines. Int J Biochem Cell Biol (2009) 2.59
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42
Mammalian polyamine metabolism and function. IUBMB Life (2009) 2.33
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry (2006) 2.13
Polyamine catabolism and disease. Biochem J (2009) 1.79
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci U S A (2006) 1.74
AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res (2006) 1.61
NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci (2007) 1.59
Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry (2007) 1.47
Polyamines and apoptosis. J Cell Mol Med (2005) 1.45
Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry (2005) 1.42
Synaptic mGluR activation drives plasticity of calcium-permeable AMPA receptors. Nat Neurosci (2009) 1.39
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav (2009) 1.37
Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry (2009) 1.31
Acetylderivatives as intermediates in polyamine catabolism. Int J Biochem (1981) 1.29
Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res (2004) 1.29
The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory. Prog Brain Res (2008) 1.20
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Polyamines as clinical laboratory tools. Clin Chim Acta (2004) 1.13
AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets (2007) 1.08
The natural polyamines and the immune system. Prog Drug Res (1994) 1.04
Astrocytes, not neurons, show most prominent staining for spermidine/spermine-like immunoreactivity in adult rat brain. Glia (1997) 1.03
Mechanisms of group I mGluR-dependent long-term depression of NMDA receptor-mediated transmission at Schaffer collateral-CA1 synapses. J Neurophysiol (2008) 1.02
Polyamine transport, accumulation, and release in brain. J Neurochem (2003) 1.01
Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu Rev Pharmacol Toxicol (1995) 1.00
Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol Pharmacol (1997) 0.99
Implication of the polyamine system in mental disorders. J Psychiatry Neurosci (2008) 0.97
Spermine: an anti-oxidant and anti-inflammatory agent. Free Radic Biol Med (1991) 0.96
Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet (2009) 0.95
Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet (2009) 0.94
Sexual dimorphism of ornithine decarboxylase in the mouse adrenal: influence of polyamine deprivation on catecholamine and corticoid levels. Am J Physiol Endocrinol Metab (2006) 0.93
Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell Mol Neurobiol (2003) 0.92
Polyamine and magnesium contents and polypeptide synthesis as a function of cell growth. Biochem Biophys Res Commun (1975) 0.92
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol (2008) 0.91
Neuronal and glial responses to polyamines in the ischemic brain. Curr Neurovasc Res (2005) 0.90
Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction. Amino Acids (2002) 0.89
AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins. Med Res Rev (2004) 0.88
Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Behav Brain Res (2009) 0.87
A quantitative GC-MS method for three major polyamines in postmortem brain cortex. J Mass Spectrom (2009) 0.87
Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust N Z J Psychiatry (2009) 0.86
Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.86
Spermine improves recognition memory deficit in a rodent model of Huntington's disease. Neurobiol Learn Mem (2009) 0.86
Age and gender differences in response to neonatal ethanol withdrawal and polyamine challenge in organotypic hippocampal cultures. Alcohol Clin Exp Res (2008) 0.85
The development of a brain bank. J Neural Transm Suppl (1993) 0.85
Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol (2003) 0.84
Influence of SAMe on the modifications of brain polyamine levels in an animal model of depression. Neuroreport (2001) 0.83
Effect of immobilization stress on brain polyamine levels in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull (2002) 0.83
The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids (2009) 0.82
Characterization of NMDA induced depression in rat hippocampus: involvement of AMPA and NMDA receptors. Neurosci Lett (2004) 0.82
Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp Neurol (1993) 0.81
NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex. Neurobiol Aging (1993) 0.81
AMPA and NMDA currents show different short-term depression in the dorsal lateral geniculate nucleus of the rat. J Physiol (2002) 0.81
Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol Psychiatry (1995) 0.81
Stress-induced dynamic changes in mouse brain polyamines. Role in behavioral reactivity. Brain Res (2002) 0.80
Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode. Anal Chim Acta (2006) 0.79
Cyclic changes of plasma spermine concentrations in women. Life Sci (2002) 0.79
Pattern recognition analysis of polyamines in the plasma of rat models with adenovirus infection. Clin Chim Acta (2007) 0.78
Rapid and simultaneous determination of hair polyamines as N-heptafluorobutyryl derivatives by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.78
Determination of hair polyamines as N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry. J Chromatogr A (2000) 0.78
Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res (1994) 0.78
Polyamines modulate the binding of GABAA-benzodiazepine receptor ligands in membranes from the rat forebrain. Neuropharmacology (1992) 0.78
Gender-related differences in polyamine oxidase activity in rat tissues. Amino Acids (1999) 0.77
Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse (1997) 0.77
Aminoanthraquinones as novel ligands at the polyamine binding site on the N-methyl-D-aspartate receptor complex. Bioorg Med Chem Lett (2000) 0.76
Design, synthesis, and pharmacological characterization of polyamine toxin derivatives: potent ligands for the pore-forming region of AMPA receptors. ChemMedChem (2006) 0.76
[Polyamine studies of schizophrenia patients]. Vrach Delo (1986) 0.76
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci (2009) 10.17
Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet (2007) 4.54
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci (2003) 2.67
Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry (2005) 2.54
Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One (2008) 2.40
Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry (2006) 2.13
Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol Psychiatry (2012) 2.13
Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology (2010) 2.09
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med (2008) 2.08
Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry (2004) 2.02
Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am J Psychiatry (2009) 1.95
Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers. Biol Psychiatry (2011) 1.92
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet (2008) 1.78
Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One (2009) 1.78
Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat. J Neurosci (2004) 1.76
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med (2013) 1.70
Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum (2005) 1.67
Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression. J Clin Psychiatry (2007) 1.58
Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry (2012) 1.57
Diagnosing zygosity in infant twins: physical similarity, genotyping, and chorionicity. Twin Res (2003) 1.56
Sexual orientation and gender identity in youth suicide victims: an exploratory study. Can J Psychiatry (2010) 1.54
The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PLoS One (2013) 1.51
Deletion of the gene encoding G0/G 1 switch protein 2 (G0s2) alleviates high-fat-diet-induced weight gain and insulin resistance, and promotes browning of white adipose tissue in mice. Diabetologia (2014) 1.49
Psychiatric risk factors for motor vehicle fatalities in young men. Can J Psychiatry (2005) 1.48
Biosynthesis of the N-linked glycan in Campylobacter jejuni and addition onto protein through block transfer. J Bacteriol (2006) 1.46
Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus. Proc Natl Acad Sci U S A (2012) 1.45
Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology (2012) 1.45
An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord (2006) 1.44
Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry (2005) 1.42
Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur J Neurosci (2004) 1.39
Environmental regulation of the development of mesolimbic dopamine systems: a neurobiological mechanism for vulnerability to drug abuse? Psychoneuroendocrinology (2001) 1.37
Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol (2014) 1.37
Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell. J Neurosci (2013) 1.35
Genome wide gene expression studies in mood disorders. OMICS (2006) 1.35
Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol (2007) 1.31
Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology (2001) 1.31
Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry (2009) 1.31
Predicting suicide attempts in young adults with histories of childhood abuse. Br J Psychiatry (2008) 1.28
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27
The neurodevelopmental origins of suicidal behavior. Trends Neurosci (2011) 1.26
MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One (2012) 1.25
Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry (2013) 1.25
Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry (2007) 1.23
MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet (2009) 1.21
The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry (2010) 1.21
Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One (2012) 1.20
A deletion in tropomyosin-related kinase B and the development of human anxiety. Biol Psychiatry (2010) 1.19
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ (2011) 1.18
The relationship of impulsive aggressiveness to suicidality and other depression-linked behaviors. Curr Psychiatry Rep (2007) 1.18
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia. Atherosclerosis (2004) 1.17
Life trajectories and burden of adversity: mapping the developmental profiles of suicide mortality. Psychol Med (2007) 1.17
Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res (2009) 1.17
Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J Biol Chem (2007) 1.16
Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem (2010) 1.15
Characterization of impulsivity in suicide completers: clinical, behavioral and psychosocial dimensions. J Affect Disord (2006) 1.15
The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am (2008) 1.15
The effects of pH on DNA methylation state: In vitro and post-mortem brain studies. J Neurosci Methods (2008) 1.15
Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology (2011) 1.14
Suicide neurobiology. Prog Neurobiol (2009) 1.11
Alcohol and cigarette use and misuse among Hurricane Katrina survivors: psychosocial risk and protective factors. Subst Use Misuse (2009) 1.10
Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol Genet Metab (2008) 1.09
Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci (2005) 1.09
Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol (2011) 1.07
Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. Am J Hum Genet (2012) 1.07
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol (2007) 1.06
Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry (2007) 1.06
Recent and lifetime utilization of health care services by children and adolescent suicide victims: a case-control study. J Affect Disord (2009) 1.04
Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation (2014) 1.04
Current psychiatric morbidity, aggression/impulsivity, and personality dimensions in child and adolescent suicide: a case-control study. J Affect Disord (2007) 1.03
Microenvironmental determinants of adult neural stem cell proliferation and lineage commitment in the healthy and injured central nervous system. Curr Stem Cell Res Ther (2008) 1.03
H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Int J Neuropsychopharmacol (2012) 1.02
Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) (2007) 1.02
Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet (2008) 1.01
Natural history of suicidal behaviors in a population-based sample of young adults. Psychol Med (2007) 1.01
The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. Int J Neuropsychopharmacol (2010) 1.00
Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol (2006) 1.00
Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation. Can J Neurol Sci (2003) 0.99
Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent. Brain Res (2002) 0.99
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry (2010) 0.98
Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci (2010) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Systematic services audit of consecutive suicides in New Brunswick: the case for coordinating specialist mental health and addiction services. Can J Psychiatry (2008) 0.98
Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol (2005) 0.98
Implication of the polyamine system in mental disorders. J Psychiatry Neurosci (2008) 0.97
What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions. Schizophr Res (2007) 0.96
On the mechanism of demethylation of 5-methylcytosine in DNA. Bioorg Med Chem Lett (2007) 0.96
Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.95